510(k) Report

510(k) · Cleared

Recalled · Class I · 2014

Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01, 12101-21, 12101-22, 12101-23

K092638510(k) TraditionalCleared Jun 15, 2010292-day reviewClass II21 CFR 862.1345Recalls 2 (2 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Diabetes Care, Inc. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Jun 15, 2010 as substantially equivalent to K992684 (Abbott Diabetes Care, Inc., 2000) and 4 other predicates after a 292-day review. Its family tree reaches back 8 generations to 1995. 1 of the 33 devices in its family, counting itself, has a Class I recall. 4 later devices descend from it. It has been recalled 2 times, including 2 Class I recalls.

Decided
Jun 15, 2010
Review
292 days
Class
Class II
Product code
NBW
Recalls
2 (2 Class I)
Predicates
5

Its longest line of descent runs back 8 generations to K945887 (1995). 28 ancestors in all, the oldest K896951 (1990). 4 later devices descend from it, 1 citing it directly. 1 of the 33 devices in this family, counting this one, has a Class I recall.

  1. Root · 8 generations backK945887 Precision Q I D Blood Glucose Test StripsMedisense, Inc. · 1995
  2. 7 generations backK962295 Precision Qid Blood Glucose Test StripMedisense, Inc. · 1996
  3. 6 generations backK963676 Precision G Blood Glucose Testing SystemMedisense, Inc. · 1997
  4. 5 generations backK971812 Precision Qid Blood Glucose Test Strip, Precision G Blood Glucose…Medisense, Inc. · 1997
  5. 4 generations backK982303 Precision PCX Point of Care Management System , QC Manager Data…Medisense, Inc. · 1998
  6. 3 generations backK022941 Medisense Precision PCX Point of Care Management System for Blood…Abbott Laboratories · 2002
  7. 2 generations backK050500 Freestyle 600 Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2005
  8. 1 generation backK051839 Free-Style Freedom Blood Glucose Monitoring System, Model 11001Abbott Diabetes Care, Inc. · 2006 · Recalled
  9. This deviceK092638 Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01…Abbott Diabetes Care, Inc. · 2010
  10. Descendant · cites it directly · 3 of its ownK112638 Nova Max One Blood Glucose Monitor, Nova Max One Blood Glucose Test…Nova Biomedical Corporation · 2012
  11. Descendant · 2 generations on · 1 of its ownK122435 Nova One Blood Glucose MonitorNova Biomedical Corporation · 2012
  12. Descendant · 3 generations on · 0 of its ownK131013 Focus Blood Glucose Monitoring System, Focus Pro Blood Glucose…Nova Biomedical Corporation · 2013
  13. Descendant · 2 generations on · 0 of its ownK122688 Nova Max Mini Blood Glucose and B-Ketone MonitorNova Biomedical Corporation · 2013

Most influential descendants

Showing 4 of 4 · See all
  • K112638Nova Max One Blood Glucose Monitor, Nova Max One Blood Glucose Test StripsNova Biomedical Corporation · 2012 · cites it directly3descendants
  • K122435Nova One Blood Glucose MonitorNova Biomedical Corporation · 2012 · 2 generations on1descendant
  • K131013Focus Blood Glucose Monitoring System, Focus Pro Blood Glucose Monitoring SystemNova Biomedical Corporation · 2013 · 3 generations on0descendants
  • K122688Nova Max Mini Blood Glucose and B-Ketone MonitorNova Biomedical Corporation · 2013 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K945887Precision Q I D Blood Glucose Test StripsMedisense, Inc.1995—
−7K962295Precision Qid Blood Glucose Test StripMedisense, Inc.1996—
−6K963676Precision G Blood Glucose Testing SystemMedisense, Inc.1997—
−5K971812Precision Qid Blood Glucose Test Strip, Precision G Blood Glucose Test StripMedisense, Inc.1997—
−4K982303Precision PCX Point of Care Management System , QC Manager Data Manager…Medisense, Inc.1998—
−3K022941Medisense Precision PCX Point of Care Management System for Blood Glucose…Abbott Laboratories2002—
−2K050500Freestyle 600 Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc.2005—
−1K051839Free-Style Freedom Blood Glucose Monitoring System, Model 11001Abbott Diabetes Care, Inc.20062
0 (this device)K092638Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01, 12101-21…Abbott Diabetes Care, Inc.2010—
+1K112638Nova Max One Blood Glucose Monitor, Nova Max One Blood Glucose Test StripsNova Biomedical Corporation2012—
+2K122435Nova One Blood Glucose MonitorNova Biomedical Corporation2012—
+3K131013Focus Blood Glucose Monitoring System, Focus Pro Blood Glucose Monitoring SystemNova Biomedical Corporation2013—
+2K122688Nova Max Mini Blood Glucose and B-Ketone MonitorNova Biomedical Corporation2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199220
199310
199530
199620
199720
199830
200030
200110
200210
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201220
201320
FIG. 1 — Lineage of K092638, 1995–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K992684Freestyle Blood Glucose Monitoring System
Summary page 1
…~Single Analyte Control Solution, Class 1(21 CFR§ 862.1660) Product code: JJX FreeStyle Blood Glucose Monitoring System (K992684, K000582, K012014, Predicae: and K03 1260), and FreeStyle Freedom Blood Glucose Monitoring System Device:…
Abbott Diabetes Care, Inc.20002
*K000582Freestyle Blood Glucose Monitoring System, Cat NO 11001
Summary page 1
…ngle Analyte Control Solution, Class 1(21 CFR§ 862.1660) Product code: JJX FreeStyle Blood Glucose Monitoring System (K992684, K000582, K012014, Predicae: and K03 1260), and FreeStyle Freedom Blood Glucose Monitoring System Device: (K051839…
Abbott Diabetes Care, Inc.2000—
*K012014Modification to Blood Glucose Monitoring System
Summary page 1
…yte Control Solution, Class 1(21 CFR§ 862.1660) Product code: JJX FreeStyle Blood Glucose Monitoring System (K992684, K000582, K012014, Predicae: and K03 1260), and FreeStyle Freedom Blood Glucose Monitoring System Device: (K051839)…
Abbott Diabetes Care, Inc.2001—
*K031260Freestyle Blood Glucose Monitoring System, Freestyle Tracker Diabetes Management System…
Summary page 1
…FR§ 862.1660) Product code: JJX FreeStyle Blood Glucose Monitoring System (K992684, K000582, K012014, Predicae: and K03 1260), and FreeStyle Freedom Blood Glucose Monitoring System Device: (K051839) Establishment.…
Abbott Diabetes Care, Inc.2003—
*K051839Free-Style Freedom Blood Glucose Monitoring System, Model 11001
Summary page 1
…ood Glucose Monitoring System (K992684, K000582, K012014, Predicae: and K03 1260), and FreeStyle Freedom Blood Glucose Monitoring System Device: (K051839) Establishment. Abbott Diabetes Care Inc. 1360 South Loop Rd.…
Abbott Diabetes Care, Inc.20062

Also cleared against K992684: 7 other devices →

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K112638Nova Max One Blood Glucose Monitor, Nova Max One Blood Glucose Test StripsNova Biomedical Corporation20123

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 19, 2014Class IZ-1212-2014Material/Component ContaminationAbbott Diabetes Care has identified through internal testing and investigation that all non-applied voltage legacy meters have the potential to produce out of range control solution results and/or erroneously low blood glucose results…
Feb 19, 2014Class IZ-1211-2014Material/Component ContaminationAbbott Diabetes Care has identified through internal testing and investigation that all non-applied voltage legacy meters have the potential to produce out of range control solution results and/or erroneously low blood glucose results…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 3 companies; a new generation was cleared every 1.3 years on median.
  • 6 of the 28 ancestors have a recall of any class.
  • Of its descendants, K112638 (Nova Biomedical Corporation, 2012) has gone furthest, with 3 descendants of its own.
  • 7 other devices also cite its predicate K992684.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The FreeStyle 3 Blood Glucose Monitoring System is intended for use in the quantitative measurement of glucose in capillary whole blood from the finger, upper arm and palm. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and it is not intended for use on neonates…

Read the full statement (320 words)

The FreeStyle 3 Blood Glucose Monitoring System is intended for use in the quantitative measurement of glucose in capillary whole blood from the finger, upper arm and palm. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and it is not intended for use on neonates or arterial blood.

The FreeStyle 5 Blood Glucose Monitoring System is intended for use in the quantitative measurement of glucose in capillary whole blood from the finger, upper arm and palm. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and it is not intended for use on neonates or arterial blood.

The FreeStyle Flash Blood Glucose Monitoring System is intended for use in the quantitative measurement of glucose in capillary whole blood from the finger, upper arm and palm. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and it is not intended for use on neonates or arterial blood.

The FreeStyle Freedom Blood Glucose Monitoring System is intended for use in the quantitative measurement of glucose in capillary whole blood from the finger, upper arm and palm. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and it is not intended for use on neonates or arterial blood.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K092638: Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01, 12101-21, 12101-22, 12101-23.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K092638

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026